OTTAWA, April 14 (Xinhua) -- Canada on Thursday approved British drugmaker AstraZeneca's drug for the prevention of COVID-19 in immune compromised adults and children.
In a statement, Health Canada said the department has determined that the drug named "Evusheld" meets Health Canada's stringent safety, efficacy and quality requirements.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
